Shen Hong, Zhao Jianrong, Zhou Xiaohong, Li Jingbo, Wan Qing, Huang Jing, Li Hui, Wu Liqun, Yang Shungang, Wang Ping
Department of Cardiology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
Department of Cardiology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
BMC Cardiovasc Disord. 2017 May 25;17(1):136. doi: 10.1186/s12872-017-0571-9.
While exercise-based cardiac rehabilitation has a beneficial effect on heart failure hospitalization and mortality, it is limited by the presence of chronotropic incompetence (CI) in some patients. This study explored the feasibility of using wearable devices to assess impaired chronotropic response in heart failure patients.
Forty patients with heart failure (left ventricular ejection fraction, LVEF: 44.6 ± 5.8; age: 54.4 ± 11.7) received ECG Holter and accelerometer to monitor heart rate (HR) and physical activities during symptom-limited treadmill exercise testing, 6-min hall walk (6MHW), and 24-h daily living. CI was defined as maximal HR during peak exercise testing failing to reach 70% of age-predicted maximal HR (APMHR, 220 - age). The correlation between HR and physical activities in Holter-accelerometer recording was analyzed.
Of 40 enrolled patients, 26 were able to perform treadmill exercise testing. Based on exercise test reports, 13 (50%) of 26 patients did not achieve at least 70% of APMHR (CI patients). CI patients achieved a lower % APMHR (62.0 ± 6.3%) than non-CI patients who achieved 72.0 ± 1.2% of APMHR (P < 0.0001). When Holter-accelerometer recording was used to assess chronotropic response, the percent APMHR achieved during 6MHW and physical activities was significantly lower in CI patients than in non-CI patients. CI patients had a significantly shorter 6MHW distance and less physical activity intensity than non-CI patients.
The study found impaired chronotropic response in 50% of heart failure patients who took treadmill exercise testing. The wearable Holter-accelerometer recording could help to identify impaired chronotropic response to physical activities in heart failure patients.
ClinicalTrials.gov ID NCT02358603 . Registered 16 May 2014.
虽然基于运动的心脏康复对心力衰竭住院率和死亡率有有益影响,但在一些患者中受到变时性功能不全(CI)的限制。本研究探讨了使用可穿戴设备评估心力衰竭患者变时性反应受损的可行性。
40例心力衰竭患者(左心室射血分数,LVEF:44.6±5.8;年龄:54.4±11.7)接受心电图动态监测和加速度计,以监测症状限制的平板运动试验、6分钟走廊步行(6MHW)和24小时日常生活期间的心率(HR)和身体活动。CI定义为运动试验峰值时的最大心率未达到年龄预测最大心率(APMHR,220-年龄)的70%。分析动态心电图-加速度计记录中HR与身体活动之间的相关性。
40例入选患者中,26例能够进行平板运动试验。根据运动试验报告,26例患者中有13例(50%)未达到至少70%的APMHR(CI患者)。CI患者达到的APMHR百分比(62.0±6.3%)低于非CI患者,后者达到APMHR的72.0±1.2%(P<0.0001)。当使用动态心电图-加速度计记录评估变时性反应时,CI患者在6MHW和身体活动期间达到的APMHR百分比显著低于非CI患者。CI患者的6MHW距离明显较短,身体活动强度低于非CI患者。
该研究发现,在进行平板运动试验的心力衰竭患者中,50%存在变时性反应受损。可穿戴的动态心电图-加速度计记录有助于识别心力衰竭患者对身体活动的变时性反应受损情况。
ClinicalTrials.gov标识符NCT02358603。2014年5月16日注册。